Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
Harvard Bioscience, Inc. (HBIO)
Last harvard bioscience, inc. earnings: 2/26 07:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.harvardbioscience.com
Company Research
Source: Yahoo! Finance
Operating Loss (GAAP): $1.9 million. Adjusted Operating Income: $800,000 or 3.8% of revenue. Adjusted EBITDA: $1.3 million or 6% of revenue. Americas Revenue: Down 12% year-over-year in Q3 2024. Preclinical Sales: Declined 26% year-over-year. Cellular and Molecular Revenue Growth: 15% year-over-year. Europe Revenue: Down 12% year-over-year, stabilized sequentially. APAC Revenue: Down 20% year-over-year and sequentially. Adjusted EBITDA (Year-over-Year): Decreased from $2.2 million to $1.3 million. Cash Flow Used in Operations: $0.8 million in Q3 2024. Net Debt: Slightly above the end of 2023 levels. Full Year Revenue Guidance: Reduced to $93 to $96 million. Q4 Revenue Expectation: $23 to $26 million. Q4 Gross Margin Expectation: 59% to 60% range. Q4 Adjusted EBITDA Margin Expectation: Mid 10s percentage. Warning! GuruFocus has detected 2 Warning Signs with HBIO. Release Date: November 07, 2024 For the complete transcript of the earnings call, please
Show less
Read more
Impact Snapshot
Event Time:
HBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HBIO alerts
High impacting Harvard Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
HBIO
News
- In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market Transformation - Technavio [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience Announces Third Quarter 2024 Financial ResultsGlobeNewswire
- Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]Yahoo! Finance
HBIO
Earnings
- 11/7/24 - Miss
HBIO
Sec Filings
- 12/6/24 - Form S-3
- 11/14/24 - Form SC
- 11/8/24 - Form 10-Q
- HBIO's page on the SEC website